Salivary Gland Neoplasms Treatment: Introduction
· Salivary glands comprise three major secretory glands: parotid, submandibular, and sublingual, and several minor glands. The function of these glands is the production and secretion of saliva.
· Saliva is a lubricating fluid that apart from keeping the mouth and throat moist also contains digestive enzymes that help in digesting food. It also contains antibodies and other substances that help prevent infections of the mouth and throat.
Read Report Overview - https://www.transparencymarketresearch.com/salivary-gland-neoplasms-treatment-market.html
· Salivary gland neoplasm or tumor is growth of the abnormal cells that begin in the salivary glands. Salivary gland neoplasm are rare.
· Salivary gland neoplasm can form in any of salivary glands. Most of the salivary gland tumors are noncancerous, but can be cancerous in some cases. Most of the salivary gland neoplasms occur in the parotid glands.
· Salivary gland tumors are comparatively rare compared to the total incidence of head and neck region tumors. The overall incidence of salivary gland tumors varies across the world, from 0.4 to 13.5 cases per 100,000 people.
Key Drivers of Global Salivary Gland Neoplasms Treatment Market
· Cancer is the second leading cause of death globally after cardiovascular diseases. The proportion of deaths across the world due to cancer increased from 12% in 1990 to 15% in 2013.
· According to the World Health Organization (WHO), cancer accounts for 8.3 million deaths every year, with 70% new cases expected to be reported during the next 20 years.
· More than 60% of new cancer cases in the world is registered in Africa, Asia, and Central and South America, and 70% of the deaths caused by cancer globally are reported in these regions.
Request for Covid-19 Impact Analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=74348
· Each type of cancer requires unique treatment. Rise in prevalence of cancer and the need of personalized medicine are expected to boost the number of diagnostic tests. This is likely to provide significant opportunities to the players in the market.
Mucoepidermoid Carcinoma to be Most Attractive Segment
· In terms of cancer type, the global salivary gland neoplasms treatment market can be classified into mucoepidermoid carcinoma, adenoid cystic carcinoma, adenocarcinomas, malignant mixed tumors, and others
· The mucoepidermoid carcinoma segment is expected to witness significant growth during the forecast period, as mucoepidermoid carcinomas are the most common type of salivary gland neoplasms. Mucoepidermoid carcinomas are usually low grade, but these can be high or intermediate grade.
Radiation Therapy Segment to Lead Global Salivary Gland Neoplasms Treatment Market
· Based on treatment type, the global salivary gland neoplasms treatment market can be classified into surgery, radiation therapy, and chemotherapy. Radiation therapy along with surgery is the standard treatment option for most of the types of salivary gland cancers. Chemotherapy is also used, but the efficacy of chemotherapy drugs has not yet been established.
North America to Dominate the Global Salivary Gland Neoplasms Treatment Market
· In terms of region, the global salivary gland neoplasms treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is a significant market for salivary gland neoplasms treatments due to focus on health care development and presence of several key players.
· Increase in the geriatric population and high population with unhealthy habits such as tobacco consumption makes the emerging economies in Asia Pacific, Latin America, and the Middle East the most attractive markets for salivary gland neoplasms treatments
· Rise in awareness and affordability of patients in developing countries such as China, India, and Brazil are expected to provide significant opportunities in the salivary gland neoplasms treatment market in these countries
Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=74348
Key Players Operating in Global Salivary Gland Neoplasms Treatment Market
The global salivary gland neoplasms treatment market is fragmented due to the presence of international as well as local players. Key players operating in the global salivary gland neoplasms treatment market are:
· Varian Medical Systems, Inc.
· Siemens AG
· Accuray Incorporated
· Koninklijke Philips N.V.
· Elekta AB
· General Electric Company
· Merck & Co. Inc.
· Bristol-Myers Squibb
· Bayer AG
· Eli Lilly & Co.
· Hoffmann-La Roche Ltd.
· Pfizer, Inc.
· Novartis AG
· Actuate Therapeutics, Inc.
· AstraZeneca
· Genentech, Inc.
· Ascentage Pharma Group, Inc.
